Covered recipient · General Payments record
MATEO MEJIA SALDARRIAGA
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2024
$2,197.73
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $649.70 | 7 |
| Consulting Fee | $300.00 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Scientific Affairs, LLC | $279.29 | 2 |
| Karyopharm Therapeutics Inc. | $253.34 | 2 |
| Janssen Biotech, Inc. | $159.79 | 2 |
| PFIZER INC. | $150.00 | 1 |
| BioLineRx USA, Inc. | $107.28 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| BioLineRx USA, Inc. | $68.56 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145039975 | CMS |
| BioLineRx USA, Inc. | $38.72 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145039977 | CMS |
| Janssen Biotech, Inc. | $73.44 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078441325 | CMS |
| Janssen Biotech, Inc. | $86.35 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078457967 | CMS |
| Janssen Scientific Affairs, LLC | $129.29 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078855892 | CMS |
| Janssen Scientific Affairs, LLC | $150.00 | 09/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1078291739 | CMS |
| Karyopharm Therapeutics Inc. | $150.00 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145533421 | CMS |
| Karyopharm Therapeutics Inc. | $103.34 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145533425 | CMS |
| PFIZER INC. | $150.00 | 08/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131440423 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.